Phreesia, Inc. — Form D/A
Phreesia, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2017-12-11. The offering totals $40.0M, of which $34.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-12-11
- Form: D/A
- Accession: 0001412408-17-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $34.0M
- Remaining: $6.0M
- Investors: 4
- Date of first sale: 2017-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-298315
Issuer
- Name: Phreesia, Inc.
- CIK: 0001412408
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 432 PARK AVENUE S., NEW YORK, NY, 10016
- Phone: 646-747-9959
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Edward Cahill | Director | Waltham, MA |
| Chaim Indig | Director | NEW YORK, NY |
| Victor Kats | Director | PORTLAND, OR |
| DUSTY LIEB | Director | DENVER, CO |
| Scott Perricelli | Director | Philadelphia, PA |
| Alan Spoon | Director | NEW YORK, NY |
| Michael Weintraub | Director | Farmington Hills, MI |
| Thomas Altier | Executive Officer | NEW YORK, NY |
| Chaim Indig | Executive Officer | NEW YORK, NY |
| Charles Kallenbach | Executive Officer | NEW YORK, NY |
| Matthew Downs | Director | Chicago, IL |
| William Conroy | Director | Lenexa, KS |
| Rory Parness | Executive Officer | New York, NY |
| Evan Roberts | Executive Officer | New York, NY |
Other filings by this issuer (4)
More